257
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Validation and additional support for an experimental animal model of fibromyalgia

, , &
Pages 116-122 | Received 22 Jan 2014, Accepted 29 Apr 2014, Published online: 01 Jul 2014

References

  • Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the Classification of Fibromyalgia report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33(2):160–72.
  • Yunus MB. The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep. 2001;3(2):128–34.
  • Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med. 2002;5(2):42–47.
  • Sluka KA. Pain syndromes: Myofascial pain and fibromyalgia. In: Sluka KA, editor. Mechanisms and Management of Pain for the Physical Therapist. Seatlle: IASP Press; 2009. p. 277–95.
  • Sluka KA. Is it possible to develop an animal model of fibromyalgia? Pain. 2009;146(1–2):3–4.
  • Dohrenbusch R, Sodhi H, Lamprecht J, Genth E. Fibromyalgia as a disorder of perceptual organization? An analysis of acoustic stimulus processing in patients with widespread pain. Z Rheumatol. 1997;56(6):334–41.
  • Green PG, Alvarez P, Gear RW, Mendoza D, Levine JD. Further validation of a model of fibromyalgia syndrome in the rat. J Pain. 2011;12(7):811–18.
  • Brown AS, Levine JD, Green PG. Sexual dimorphism in the effect of sound stress on neutrophil function. J Neuroimmunol. 2008;205:25–31.
  • Nagakura Y, Oe T, Aoki T, Matsuoka N. Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain. 2009;146:26–33.
  • Nishiyori M, Ueda H. Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia. Mol Pain. 2008;4:52.
  • Grace GM, Nielson WR, Hopkins M, Berg MA. Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol. 1999;21:477–87.
  • Glass JM, Park DC. Cognitive dysfunction in fibromyalgia. Curr Rheumatol Rep. 2001;3:123–27.
  • Munguía-Izquierdo D, Legaz-Arrese A, Moliner-Urdiales D, Reverter-Masía J. Neuropsychological performance in patients with fibromyalgia syndrome: relation to pain and anxiety. Psicothema. 2008;20:427–31.
  • Ortega E, García JJ, Bote ME, Martín-Cordero L, Escalante Y, Saavedra JM, et al. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. Exerc Immunol Rev. 2009;15:42–65.
  • Randall LO, Selitto JJ. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther. 1957; 111(4):409–19.
  • Blakeman KH, Hao JX, Xu XJ, Jacoby AS, Shine J, Crawley JN, et al. Hyperalgesia and increased neuropathic pain-like response in mice lacking galanin receptor 1 receptors. Neuroscience. 2003;117: 221–27.
  • Wiesenfeld-Hallin Z, Xu XJ, Crawley JN, Hökfelt T. Galanin and spinal nociceptive mechanisms: recent results from transgenic and knock-out models. Neuropeptides. 2005;39:207–10.
  • Chadman KK, Gong S, Scattoni ML, Boltuck SE, Gandhy SU, Heintz N, Crawley JN. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res Jun. 2008;1(3): 147–58.
  • Allchorne AJ, Broom DC, Woolf CJ. Detection of cold pain, cold allodynia and cold hyperalgesia in freely behaving rats. Mol Pain. 2005;1:36.
  • Gröticke I, Hoffmann K, Löscher W. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate. Exp Neurol. 2008; 213(1):71–83.
  • Navarro E, Alonso SJ, Navarro R. Toxicity and neuropharmacological effects of elenine. Evid Based Complement Alternat Med. 2011; 2011:312524.
  • Simon P, Chermat R, Doaré L, Bourin M, Farinotti R. Unexpected interactions of some psychotropic drugs with barbital and pentobarbital effects in mice. J Pharmacol. 1982;13(2):241–52.
  • De las Heras B, Navarro A, Díaz-Guerra MJ, Bermejo P, Castrillo A, Boscá L, Villar A. Inhibition of NOS-2 expression in macrophages through the inactivation of NF- kappaB by andalusol. Br J Pharmacol. 1999; 128(3):605–12.
  • Fernández MA, Tornos MP, García MD, de las Heras B, Villar AM, Sáenz MT. Anti-inflammatory activity of abietic acid, a diterpene isolated from Pimenta racemosa var. grissea. J Pharm Pharmacol. 2003;53(6):867–72.
  • Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, [15N]-nitrate in biological fluids. Anal Biochem. 1981;126(1):131–8.
  • Munro G. Comment on Biogenic amine depletion as a putative animal model of fibromyalgia [Pain 2009;146:26–33]. Pain. 2010; 148(1):172–3.
  • Nishiyori M, Uchida H, Nagai J, Araki K, Mukae T, Kishioka S, Ueda H. Permanent relief from intermittent cold stress-induced fibromyalgia-like abnormal pain by repeated intrathecal administration of antidepressants. Mol Pain. 2011;7:69.
  • Jay GW, Demattos RB, Weinstein EJ, Philbert MA, Pardo ID, Brown TP. Animal models for neural diseases. Toxicol Pathol. 2011;39(1):167–9.
  • Bardin L, Malfetes N, Newman-Tancredi A, Depoortère R. Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: Relevance to human stress-associated painful pathologies. Behav Brain Res. 2009;205(2):360–6.
  • Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis Clin North Am. 1989;15(1):1–18.
  • Henriksson KG, Bengtsson A. Fibromyalgia-a clinical entity? Can J Physiol Pharmacol. 1991;69(5):672–7.
  • Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment. J Rheumatol Suppl. 2005;75:6–21.
  • Aaron LA, Bradley LA, Alarcón GS, Alexander RW, Triana-Alexander M, Martin MY, Alberts KR. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum. 1996;39(3):436–45.
  • Moldofsky H. The significance, assessment, and management of nonrestorative sleep in fibromyalgia syndrome. CNS Spectr. 2008;13(3 Suppl 5):22–6.
  • Shur EA. Feeling bad in more ways than one: comordibity patterns of medically unexplained and psychiatric conditions. J Gen Intern Med. 1999;22(6):3541–6.
  • Miyasaka K, Funakoshi A. Is the OLETF rat a good model of central sensitization? J Pharmacol Sci. 2007;105(4):373.
  • de Souza JB, Potvin S, Goffaux P, Charest J, Marchand S. The deficit of pain inhibition in fibromyalgia is more pronounced in patients with comorbid depressive symptoms. Clin J Pain. 2009;25(2):123–7.
  • Becker S, Schweinhardt P. Dysfunctional neurotransmitter systems in fibromyalgia, their role in central stress circuitry and pharmacological actions on these systems. Pain Res Treat. 2012;2012:741–6.
  • Arnold LM, Goldenberg DL, Stanford SB, Lalonde JK, Sandhu HS, Keck PE Jr, et al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blinded, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56(4):1336–44.
  • Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, et al. A 14-week, randomized, doubled-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia. J Pain. 2008;9(9):792–805.
  • Satyanarayana PS, Jain NK, Singh S, Kulkarni SK. Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia. Inflammopharmacology. 2004;12(1):57–68.
  • Cho KI, Lee JH, Kim SM, Lee HG, Kim TI. Assessment of endothelial function in patients with fibromyalgia-cardiac ultrasound study. Clin Rheumatol. 2011;30(5):647–54.
  • Grippo AJ, Johnson AK. Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models. Stress. 2009;12(1):1–21.
  • Ghiadoni L, Donald AE, Cropley M, Mullen MJ, Oakley G, Taylor M, et al. Mental stress induces transient endothelial dysfunction in humans. Circulation. 2000;102(20):2473–8.
  • Fernandez-Arche A, Saenz MT, Arroyo M, de la Puerta R, Garcia MD. Topical anti-inflammatory effect of tirucallol, a triterpene isolated from Euphorbia lactea latex. Phytomedicine. 2010;17(2): 146–8.
  • Iqbal R, Mughal MS, Arshad N, Arshad M. Pathophysiology and antioxidant status of patients with fibromyalgia. Rheumatol Int. 2011;31(2):149–152.
  • Arranz LI, Canela MA, Rafecas M. Fibromyalgia and nutrition, what do we know? Rheumatol Int. 2010;30(11):1417–27.
  • Nagakura Y, Takahashi M, Noto T, Sekizawa T, Oe T, Yoshimi E, et al. Different pathophysiology underlying animal models of fibromyalgia and neuropathic pain: comparison of reserpine-induced myalgia and chronic constriction injury rats. Behav Brain Res. 2012;226(1):242–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.